Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT III

Impella-supported HRPCI is a viable alternative for high-risk patients deemed ineligible for CABG. Patients turned down by a CTS had worse clinical outcomes than those who declined surgery. The underestimation of 30-day mortality by the STS risk score suggests the need for improved risk prediction models in this high-risk cohort.

Authors

Institutions

Publication Details

Journal
Journal of the Society for Cardiovascular Angiography & Interventions
Published
2025-08-26
DOI
https://doi.org/10.1016/j.jscai.2025.103859
Citations
1
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT III

Wayne Batchelor, Behnam Tehrani, Arsalan Abu‐Much, Mir B. Basir et al.
1 citations
Journal of the Society for Cardiovascular Angiography & Interventions
Coronary Interventions and Diagnostics
2.01
article

Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT III

Wayne Batchelor, Behnam Tehrani, Arsalan Abu‐Much, Mir B. Basir, Michael Schonning, Björn Redfors, Alexander G. Truesdell, Cindy L. Grines, Batla Falah, Alejandro Lemor, Deepak Acharya, Suzanne J. Baron, Julia B Thompson, Aditya Bharadwaj, Tayyab Shah, Samer M Garas, Yiran Zhang, David Jonathan Cohen, Yousuf Shah, William W O'Neill
article en
1 citations

Abstract

Impella-supported HRPCI is a viable alternative for high-risk patients deemed ineligible for CABG. Patients turned down by a CTS had worse clinical outcomes than those who declined surgery. The underestimation of 30-day mortality by the STS risk score suggests the need for improved risk prediction models in this high-risk cohort.

Journal of the Society for Cardiovascular Angiography & InterventionsVol. 4(10)
Northside Hospital (US), Loma Linda University Medical Center (US), Ascension (US), University of Arizona (US), Henry Ford Health System (US), Cornell University (US), Loma Linda University (US), Inova Fairfax Hospital (US), Sahlgrenska University Hospital (SE), Jackson Memorial Hospital (US), University of Mississippi Medical Center (US), Yale University (US), Massachusetts General Hospital (US), St. Francis Hospital (US), St. Vincent Hospital (US), Baim Institute for Clinical Research (US), University of Pennsylvania Health System (US), Cardiovascular Research Foundation (US), St. Vincent's HealthCare (US), St. Vincent's Medical Center (US), Weill Cornell Medicine (US), University of Rochester (US), University of Gothenburg (SE)
Abiomed
Gender equality
Openalex Percentile: Top 12%
Coronary Interventions and Diagnostics
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.